<br>A lesson learned from COVID-19: The importance of non-inferiority (NI) trials for developing new antimicrobial agents before widespread need</br><em> – by John Rex</em>
6 October 2020

A lesson learned from COVID-19: The importance of non-inferiority (NI) trials for developing new antimicrobial agents before widespread need ...

more
<br>Why we need a new access model for antibiotics</br><em> – by Yann Ferrisse and Fernando Pascual Martinez</em>
1 October 2020

Why we need a new access model for antibiotics – by Yann Ferrisse and Fernando Pascual Martinez

more
<br>Moving from paper to action – The status of National AMR Action Plans in African countries</br><em> – by Mirfin Mpundu</em>
25 September 2020

Moving from paper to action – The status of National AMR Action Plans in African countries – by Mirfin Mpundu

more
<br>Knowledge sharing for antimicrobial research: AntibioticDB and SPARK and why researchers should use them</br><em> – by Jack Stone and Maria Laura Ciusa</em>
5 August 2020

Knowledge sharing for antimicrobial research: AntibioticDB and SPARK and why researchers should use them – by Jack Stone and Maria Laura ...

more
<br>Getting the most out of antimicrobial surveillance</br><em> – by Mariana Castanheira</em>
28 May 2020

Getting the most out of antimicrobial surveillance – by Mariana Castanheira

more
<br>COVID-19 and antimicrobial resistance: Are there any unknowns that will become known?</br><em> – by Stephan Harbarth</em>
13 May 2020

COVID-19 and antimicrobial resistance: Are there any unknowns that will become known? – by Stephan Harbarth

more
<br>COVID-19 and its impact on antimicrobial stewardship</br><em> – by Andrew Seaton</em>
30 April 2020

COVID-19 and its impact on antimicrobial stewardship – by Andrew Seaton

more
<br>The critical need for alternative approaches to address antibiotic treatment failure</br><em> – by Bob Hancock</em>
16 April 2020

The critical need for alternative approaches to address antibiotic treatment failure – by Bob Hancock

more
<br>COVID-19 and why tackling the silent crisis of drug-resistant infections matters more than ever</br><em> – by Manica Balasegaram</em>
2 April 2020

COVID-19 and why tackling the silent crisis of drug-resistant infections matters more than ever – by Manica Balasegaram

more
<br>The antibiotics marketplace collapse: It’s just math, and it’s a solvable equation</br><em> – by Ryan Cirz and Kevin Krause</em>
17 March 2020

The antibiotics marketplace collapse: It’s just math, and it’s a solvable equation – by Ryan Cirz and Kevin Krause

more
© All Rights Reserved
✕

Newsletter

Subscribe to our newsletter to stay up-to-date about our webinars, conferences and other activities.



View previous newsletters

Go to Top